{"title":"高脑钠肽水平预测心房纤颤消融患者低压区患病率和心律不佳结局。","authors":"Yasuhiro Matsuda, Masaharu Masuda, Mitsutoshi Asai, Osamu Iida, Shin Okamoto, Takayuki Ishihara, Kiyonori Nanto, Takashi Kanda, Takuya Tsujimura, Shota Okuno, Yosuke Hata, Hiroyuki Uematsu, Toshiaki Mano","doi":"10.4022/jafib.2279","DOIUrl":null,"url":null,"abstract":"<p><strong>Backgrounds: </strong>The prevalence of residual left atrial low-voltage areas (LVAs) is associated with atrial fibrillation (AF) recurrence after pulmonary vein isolation. Brain natriuretic peptide (BNP) may be increased in AF patients and may raise AF recurrence risk after catheter ablation. We investigated the association between BNP and the prevalence of LVAs.</p><p><strong>Methods: </strong>One hundred and eighty three consecutive AF cases were retrospectively enrolled that underwent initial ablation for AF (persistent AF, 82 [45%] patients). Serum BNP was measured before ablation and the natural logarithm of BNP (log-BNP) was calculated. Low-voltage points were defined as sites with left atrial electrogram amplitude <0.5 mV. LVAs were defined as regions with ≥5% low-voltage points across the total surface area of the left atrium.</p><p><strong>Results: </strong>Of the 183 patients, 38 (21%) had LVAs. Patients with LVAs demonstrated higher log-BNP (4.8±0.9 vs. 3.9±1.2, P<0.001). The optimal cut-off value of log-BNP was 4.4, which was equivalent to 81 pg/mL of BNP. LVAs were more frequent in patients with higher log-BNP. In multivariate analysis, log-BNP >4.4 was an independent predictor of LVAs (odds ratio 2.7 [95% confidence interval 1.01-7.1], P=0.048). Freedom from AF recurrence was significantly lower in patients with than without high log-BNP (P=0.007).</p><p><strong>Conclusions: </strong>BNP correlated with the prevalence of left atrial LVAs and AF recurrence in patients with AF undergoing catheter ablation.</p>","PeriodicalId":15072,"journal":{"name":"Journal of atrial fibrillation","volume":"13 3","pages":"2279"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691330/pdf/jafib-13-02279.pdf","citationCount":"0","resultStr":"{\"title\":\"High Brain Natriuretic Peptide Level Predicts The Prevalence Of Low-Voltage Areas And Poor Rhythm Outcome In Patients Undergoing Atrial Fibrillation Ablation.\",\"authors\":\"Yasuhiro Matsuda, Masaharu Masuda, Mitsutoshi Asai, Osamu Iida, Shin Okamoto, Takayuki Ishihara, Kiyonori Nanto, Takashi Kanda, Takuya Tsujimura, Shota Okuno, Yosuke Hata, Hiroyuki Uematsu, Toshiaki Mano\",\"doi\":\"10.4022/jafib.2279\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Backgrounds: </strong>The prevalence of residual left atrial low-voltage areas (LVAs) is associated with atrial fibrillation (AF) recurrence after pulmonary vein isolation. Brain natriuretic peptide (BNP) may be increased in AF patients and may raise AF recurrence risk after catheter ablation. We investigated the association between BNP and the prevalence of LVAs.</p><p><strong>Methods: </strong>One hundred and eighty three consecutive AF cases were retrospectively enrolled that underwent initial ablation for AF (persistent AF, 82 [45%] patients). Serum BNP was measured before ablation and the natural logarithm of BNP (log-BNP) was calculated. Low-voltage points were defined as sites with left atrial electrogram amplitude <0.5 mV. LVAs were defined as regions with ≥5% low-voltage points across the total surface area of the left atrium.</p><p><strong>Results: </strong>Of the 183 patients, 38 (21%) had LVAs. Patients with LVAs demonstrated higher log-BNP (4.8±0.9 vs. 3.9±1.2, P<0.001). The optimal cut-off value of log-BNP was 4.4, which was equivalent to 81 pg/mL of BNP. LVAs were more frequent in patients with higher log-BNP. In multivariate analysis, log-BNP >4.4 was an independent predictor of LVAs (odds ratio 2.7 [95% confidence interval 1.01-7.1], P=0.048). Freedom from AF recurrence was significantly lower in patients with than without high log-BNP (P=0.007).</p><p><strong>Conclusions: </strong>BNP correlated with the prevalence of left atrial LVAs and AF recurrence in patients with AF undergoing catheter ablation.</p>\",\"PeriodicalId\":15072,\"journal\":{\"name\":\"Journal of atrial fibrillation\",\"volume\":\"13 3\",\"pages\":\"2279\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691330/pdf/jafib-13-02279.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of atrial fibrillation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4022/jafib.2279\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/10/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of atrial fibrillation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4022/jafib.2279","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景:肺静脉隔离后左房低压区残留与房颤(AF)复发相关。脑钠肽(BNP)可能在房颤患者中升高,并可能增加导管消融后房颤复发的风险。我们调查了BNP与LVAs患病率之间的关系。方法:回顾性纳入183例连续房颤患者,均接受房颤初始消融治疗(顽固性房颤82例[45%])。消融前测定血清BNP,计算BNP的自然对数(log-BNP)。结果:183例患者中,38例(21%)有左心房电图振幅。llvas患者的log-BNP较高(4.8±0.9 vs. 3.9±1.2,P4.4是llvas的独立预测因子(比值比为2.7[95%可信区间1.01-7.1],P=0.048)。与没有高对数bnp的患者相比,AF复发的自由度明显降低(P=0.007)。结论:BNP与房颤导管消融患者左房LVAs患病率及房颤复发相关。
High Brain Natriuretic Peptide Level Predicts The Prevalence Of Low-Voltage Areas And Poor Rhythm Outcome In Patients Undergoing Atrial Fibrillation Ablation.
Backgrounds: The prevalence of residual left atrial low-voltage areas (LVAs) is associated with atrial fibrillation (AF) recurrence after pulmonary vein isolation. Brain natriuretic peptide (BNP) may be increased in AF patients and may raise AF recurrence risk after catheter ablation. We investigated the association between BNP and the prevalence of LVAs.
Methods: One hundred and eighty three consecutive AF cases were retrospectively enrolled that underwent initial ablation for AF (persistent AF, 82 [45%] patients). Serum BNP was measured before ablation and the natural logarithm of BNP (log-BNP) was calculated. Low-voltage points were defined as sites with left atrial electrogram amplitude <0.5 mV. LVAs were defined as regions with ≥5% low-voltage points across the total surface area of the left atrium.
Results: Of the 183 patients, 38 (21%) had LVAs. Patients with LVAs demonstrated higher log-BNP (4.8±0.9 vs. 3.9±1.2, P<0.001). The optimal cut-off value of log-BNP was 4.4, which was equivalent to 81 pg/mL of BNP. LVAs were more frequent in patients with higher log-BNP. In multivariate analysis, log-BNP >4.4 was an independent predictor of LVAs (odds ratio 2.7 [95% confidence interval 1.01-7.1], P=0.048). Freedom from AF recurrence was significantly lower in patients with than without high log-BNP (P=0.007).
Conclusions: BNP correlated with the prevalence of left atrial LVAs and AF recurrence in patients with AF undergoing catheter ablation.